中国医院用药评价与分析2024,Vol.24Issue(4) :487-490.DOI:10.14009/j.issn.1672-2124.2024.04.023

胰岛素专项集采政策对某院胰岛素使用情况的影响分析

Effects of Centralized Volume-Based Procurement Policy on Application of Insulin in A Hospital

陈伟薇 刘玉龙 张灵 邱季
中国医院用药评价与分析2024,Vol.24Issue(4) :487-490.DOI:10.14009/j.issn.1672-2124.2024.04.023

胰岛素专项集采政策对某院胰岛素使用情况的影响分析

Effects of Centralized Volume-Based Procurement Policy on Application of Insulin in A Hospital

陈伟薇 1刘玉龙 1张灵 1邱季1
扫码查看

作者信息

  • 1. 合肥市第一人民医院滨湖院区药学部,合肥 230041
  • 折叠

摘要

目的:探讨胰岛素集中带量采购(以下简称"集采")政策对该院胰岛素使用情况的影响,为医院实施集采政策提供参考意见.方法:以该院胰岛素为研究对象,采用回顾性分析的方法,调取集采政策实施前 1 年(2021 年 5 月至 2022 年 4 月)和集采政策实施后 1 年(2022 年 9 月至 2023 年 8 月)胰岛素的品种、规格、厂家、价格、使用量和销售金额等数据,分别从降幅、用药频度(DDDs)、限定日剂量(DDC)、集采完成度等方面进行分析.结果:集采政策实施后,该院胰岛素的品种由原先的 11 种增至 17 种,原目录中除了胰岛素注射液未被集采,其余品种均被集采,新目录增加了国家医保谈判药品德谷门冬双胰岛素注射液;胰岛素各品种的价格均有不同程度的下降,降幅最大的为甘精(预充)胰岛素注射液(来得时),达 61.00%(从 184.62 元/支降至 72.00 元/支);胰岛素的总销售金额从3 452 075.99元降至 2 496 220.60 元,共节约资金 955 855.39 元;胰岛素各品种的DDDs均有不同程度提高,DDC均有所下降;基本完成集采任务量.结论:集采政策实施后,该院胰岛素的选择和使用较合理,对国家集采政策配合度高,切实减轻了部分患者的经济负担,减少了医疗保障基金支出,但政策的推进仍需医院、医师和药师共同努力.

Abstract

OBJECTIVE:To probe into the effects of centralized volume-based procurement policy(hereinafter referred to as"centralized procurement policy")on application of insulin in the hospital,so as to provide reference for the implementation of centralized procurement policy.METHODS:Taking insulin in the hospital as research object,a retrospective analysis was used to retrieve the data on insulin's varieties,specifications,manufacturers,prices,usage amount and consumption sum in one year before the implementation of centralized procurement policy(from May 2021 to Apr.2022)and one year after the implementation of centralized procurement policy(from Sept.2022 to Aug.2023),the decreasing amplitude,defined daily dose system(DDDs),defined daily cost(DDC)and completion degree of centralized procurement were analyzed.RESULTS:After the implementation of centralized procurement policy,the varieties of insulin in the hospital increased from 11 to 17,all the varieties in the original catalog were centralized procurement except for insulin injection,and the new catalog added the national health insurance negotiated drug of insulin degludec and insulin aspart injection;the price of each variety of insulin had a different degree of decrease,and that of the glargin(pre-filled)insulin injection(Laideshi)was the greatest,which was 61.00%(from 184.62 yuan per injection to 72.00 yuan per injection).The total consumption sum of insulin decreased from 3 452 075.99 yuan to 2 496 220.60 yuan,decreased by 955 855.39 yuan.The DDDs of each variety of insulin increased at different degrees,while the DDC decreased to some extent;the volume of centralized procurement tasks was basically completed.CONCLUSIONS:After the implementation of centralized procurement policy,the selection and application of insulin in the hospital is more rational,with high degree of cooperation to the national centralized procurement policy,which effectively relieves the economic burden of some patients and reduces the expenditure of national medical insurance fund,yet the promotion of the policy still requires the joint efforts of the hospital,clinicans and pharmacists.

关键词

国家集中带量采购政策/胰岛素/用药频度/限定日剂量

Key words

National centralized drug volume-based procurement policy/Insulin/Defined daily dose system/Defined daily cost

引用本文复制引用

基金项目

2022年安徽省卫生健康科研项目(AHWJ2022b104)

出版年

2024
中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
参考文献量15
段落导航相关论文